White label ELPA - ClinicalTrials.eu

Study on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
Study on Insulin Lispro and Insulin Human for Managing Blood Sugar After Meals in Type 1 Diabetes Patients with Different Gastric Emptying Rates

Not recruiting

1 1 1 1
Investigated diseases:
- Type 1 diabetes mellitus
Investigated drugs:
- Insulin Human (Rdna)
- Insulin Lispro
Study on the Effectiveness and Safety of Ravulizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Not recruiting

4 1 1 1
Investigated drugs:
- Ravulizumab
Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

Not recruiting

3 1 1
Investigated diseases:
- Breast cancer metastatic
Investigated drugs:
+5
Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Rosnilimab
+4
Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

Not recruiting

3 1 1
Investigated drugs:
+7
Study of BLU-263 and Azacitidine for Patients with Advanced Systemic Mastocytosis and Other KIT Altered Blood Cancers

Not recruiting

1 1 1 1
Investigated diseases:
- Systemic mastocytosis
Investigated drugs:
- Blu-263 Phosphate
- Azacitidine
Study of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery

Not recruiting

2 1 1
Investigated diseases:
- Transitional cell carcinoma
Investigated drugs:
- Mrna-4157
- Pembrolizumab
Study on the Effects and Safety of Namilumab for Patients with Chronic Lung Sarcoidosis

Not recruiting

2 1
Investigated drugs:
- Namilumab
Study of Mosunetuzumab and Polatuzumab Vedotin for Patients with Diffuse Large B-Cell Lymphoma After Initial Treatment or in Elderly/Unfit Untreated Patients

Not recruiting

1 1 1 1
Investigated diseases:
- Diffuse large B-cell lymphoma recurrent
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies